Related Experiment Videos
Introduction: target organ meeting on the cardiovascular system
Environmental Health Perspectives
|October 1, 1978
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Hepatic cholesterol metabolism following exposure to carbon disulfide in phenobarbital-treated rats.
Archives of environmental contamination and toxicology·1989
Hepatic cholesterol metabolism as a function of carbon disulfide concentration and treatment with phenobarbital.
American Industrial Hygiene Association journal·1988
Oncogenic response of strain A/J mice to inhaled chemicals.
Journal of toxicology and environmental health·1986
Calibration of a system for the computer-assisted operation of a small animal inhalation facility.
Environmental health perspectives·1984
Exposures to Drinking Water Contaminants in Community Water Systems and Risk of Ovarian Cancer in the California Teachers Study Cohort.
Environmental health perspectives·2026
Source-Specific Air Pollution and Risk of Chronic Obstructive Pulmonary Disease: A Pooled Cohort Study.
Environmental health perspectives·2026
Wildfire-Season Fine Particulate Matter Exposure and Associations with Influenza and Influenza-like-Illness Risk in the Western USA.
Environmental health perspectives·2026
In Utero Per- and Polyfluoroalkyl Substances (PFAS) Exposure and Changes in Infant T Helper Cell Development among UPSIDE-ECHO Cohort Participants.
Environmental health perspectives·2026
Multibehavioral Phenotyping in Early-Life-Stage Zebrafish for Identifying Disruptors of Nonassociative Learning.
Environmental health perspectives·2026
A New Mouse Model for Ozone Health Effects Research.
Environmental health perspectives·2026
Associations of Cholesin and GPR146 with atherosclerotic plaque stability: integrated bioinformatics and functional analyses.
Frontiers in cardiovascular medicine·2026
Caveolin-1 levels associated with coronary artery disease in Chinese participants: a retrospective cohort study.
Frontiers in cardiovascular medicine·2026
PCSK9 inhibitors for lipid-lowering treatment in patients with atherosclerotic cardiovascular disease: a health technology assessment.
Frontiers in cardiovascular medicine·2026